Company CVAbout Indoco Remedies Ltd 
Indoco Remedies Ltd
Small Cap
Pharmaceuticals & Drugs
Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research. The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Company Coordinates
Company Details
Indoco House 166 C S T Road, Santacruz (East) Kalina Mumbai Maharashtra : 400098
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 18.44 Cr
Number of Shares
9.22 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
29-Mar-2024
9.22
18.44
31850
2
Issued under ESOP Scheme
17-May-2012
6.14
12.29
49146856
2
Stock Split
17-May-2012
9.22
18.43
30716785
2
Bonus
17-May-2012
6.14
12.29
49146856
2
Stock Split
17-May-2012
9.22
18.43
30716785
2
Bonus
18-Oct-2007
1.23
12.29
465000
10
DeMerger
18-Oct-2007
1.23
12.29
465000
10
DeMerger
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 9 Schemes (18.21%)
FIIs
Held by 36 FIIs (1.25%)
Promoter with highest holding
Spa Holdings Pvt Ltd (19.89%)
Highest Public shareholder
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund (4.81%)
Individual Investors Holdings
16.07%
Board of Directors
Management
Designation
Remuneration
Suresh G Kare
Chairman & Wholetime Director
5.39 cr
Aditi Kare Panandikar
Managing Director
7.39 cr
Sundeep V Bambolkar
Joint Managing Director
6.55 cr
Rajiv Kakodkar
Independent Non Exe. Director
7.2 lacs
D M Gavaskar
Independent Non Exe. Director
6.4 lacs
Vasudha V Kamat
Independent Non Exe. Director
5.6 lacs
Abhijit Y Gore
Independent Non Exe. Director
5.2 lacs
Anand Nadkarni
Non Executive Director
3.6 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Sale of Product - Pharmaceutical Goods
892.72
92.25%
Service Income
48.65
5.03%
Other Operating Revenue - Exchange Gain
16.47
1.70%
Sale of Product - Pharmaceutical Goods
Sale of Product - Pharmaceutical Goods
Service Income
Service Income
Other Operating Revenue - Exchange Gain
Other Operating Revenue - Exchange Gain
Stock DNARevenue and Profits:
Net Sales:
411 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-26 Cr
Pharmaceuticals & Drugs
INR 2,142 Cr (Small Cap)
NA (Loss Making)
33
0.66%
0.73
2.25%
1.91
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
